Filed Pursuant to Rule 424(b)(7)
Registration No. 333-267226
PROSPECTUS SUPPLEMENT
(to Prospectus dated September 1, 2022)
National Bank Holdings Corporation
Common Stock
This Prospectus Supplement No. 3 (“Prospectus Supplement No. 3”) supplements the prospectus dated September 1, 2022 (the “Base Prospectus”), as supplemented by the prospectus supplement dated September 1, 2022, (“Prospectus Supplement No. 1”) and supplemented by the prospectus supplement No. 2 dated January 30, 2023 (“Prospectus Supplement No. 2” and, together with the Base Prospectus, Prospectus Supplement No. 1, and Prospectus Supplement No. 3, the “prospectus”), relating to the resale of an aggregate of up to 3,096,740 shares (the “Shares”) of our Class A Common Stock, par value $0.01 (the “common stock”), which are held by the selling stockholders named in the prospectus.
The purpose of this Prospectus Supplement No. 3 is solely to supplement and amend the selling stockholders table set forth in under the caption “Selling Stockholders” beginning on page S-11 of Prospectus Supplement No. 1 to reflect certain transfers from certain Selling Stockholders previously identified in the prospectus to other parties who as a result of such transfers are being added or substituted as Selling Stockholders, which transfers are described in the footnotes of such table.
This Prospectus Supplement No. 3 is not complete without, and may not be utilized except in connection with, the prospectus. This Prospectus Supplement No. 3 is qualified by reference to the prospectus, except to the extent that the information provided by this Prospectus Supplement No. 3 supersedes information contained in the prospectus.
Our common stock is listed on the New York Stock Exchange (the “NYSE”) under the symbol “NBHC.” The last reported sale price of our common shares on March 23, 2023, was $32.12 per share.
Investing in our securities involves risks. See the “Risk Factors” on page S-8 of the original prospectus supplement and any similar section contained in the applicable prospectus and in the documents incorporated by reference into this prospectus supplement.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is March 24, 2023.